Please login to the form below
phase 3 trials
This page shows the latest phase 3 trials news and features for those working in and with pharma, biotech and healthcare.
Bristol Myers Squibb announces positive trial results for treatment of MS
In the two phase 3 trials, Zeposia treatment showed improved or preserved cognitive function in the majority of patients. ... Bristol Myers Squibb (BMS) announced that analysis from two phase 3 trials of Zeposia (ozanimod) showed that early use of the
Latest news
-
Eli Lilly and Incyte's Olumiant receives FDA approval for alopecia
The FDA based its decision on the BRAVE-AA clinical programme – BRAVE-AA1 and BRAVE-AA2 trials – the largest phase 3 AA clinical study completed to date, which assessed the safety ... The double-blind, placebo-controlled trials enrolled 1, 200
-
Sanofi and GSK share positive data for two COVID-19 booster vaccine trials
Both the COVIBOOST and phase 3 VAT02 trials showed the booster was well-tolerated, with favourable safety profiles. ... In the phase 3 VAT02 cohort 2 trial, the Sanofi/GSK vaccine candidate caused – at day 15 post-immunisation – a significant boost
-
Almirall shares positive topline results from atopic dermatitis trials
The latest data taken from the ADvocate 1 and 2 phase 3 clinical trials showed eight out of ten patients who achieved clinical response – EASI-75 – with lebrikizumab monotherapy at 16 ... ADvocate 1 and 2 results add to the exciting, growing body of
-
Dermavant’s Vtama receives FDA approval for plaque psoriasis
In the phase 3 clinical trial, Vtama cream met all primary and secondary endpoints and showed a statistically significant improvement. ... Safety and tolerability levels were consistent across all three trials (PSOARING 1, 2 and the phase 3 long-term
-
Phase 3 trial of AstraZeneca and Avillion’s PT027 shows promise for asthma patients
AstraZeneca (AZ) and Avillion have announced positive phase 3 trial results from the MANDALA study, showing that PT027 – albuterol/budesonide – demonstrated a statistically significant decrease in the risk of a severe ... The results from the phase 3
More from news
Approximately 1 fully matching, plus 206 partially matching documents found.
Latest Intelligence
-
Health technology assessments: understanding the global landscape and considerations for drug development
Clinical trial design. When feasible, phase 3 trials should be optimised to meet payer expectations. ... This step allows sponsors the opportunity to make changes to their clinical trial protocol, ensuring trials generate payer-relevant data.
-
Alzheimer’s disease: the search for a cure
trials. Ultimately, our aim is to accelerate the progression of dementia drug discovery and to increase the success of longer and more expensive later phase clinical trials. ... A quarter are in phase 3 trials, and more agents are in earlier phase 2
-
Transforming clinical trial data into a long-term asset
conduct 6.5 phase 1/2/3/4 studies in 2020. ... Without early-phase data to support pivotal phase 3 trials, drug filings for new therapies are likely to be delayed, further prolonging the all-important drug-approval process.
-
The search for effective drug treatments for COVID-19
Diseases’ (NIAID) placebo-controlled phase 3 study in patients with moderate to severe symptoms of COVID-19, including those who were critically ill, and Gilead’s global phase 3 study (SIMPLE ... Trials) evaluating five-day and ten-day dosing
-
Treatment and prevention of cardiovascular disease
Epeleuton. is the company’s first next generation synthetic omega-3 compound to enter phase 2 clinical trials. ... other omega-3 fatty acids. In a phase 2a study, it decreased triglycerides, improved glycaemic control and improved markers of
More from intelligence
Approximately 0 fully matching, plus 19 partially matching documents found.
Latest appointments
-
AZ appoints Susan Galbraith as executive vice president, oncology R&D
Previously, she led early-stage oncology R&D at AZ, a role in which she oversaw the successful progression of seven programmes into phase 3 trials, with four of those becoming
-
New hires at Nanoform, Leo Pharma and Calliditas
and bringing products to market will play a key role as we progress development of Nefecon through phase 3 clinical trials”, said Renée Aguiar-Lucander, CEO of Calliditas Therapeutics. ... With the phase 3 trial of Nefecon well underway, this is a
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Breaking the silence: It’s time to talk about the menopause
However, the acquisition of KaNDy by Bayer, and the recent unveiling by Astellas of positive topline results from two phase 3 clinical trials for their non-hormonal drug for moderate – severe
-
Licensing Deal for NP213 Nail Fungus Treatment is Another Key Milestone for NovaBiotics
Other recent progress includes NovaBiotics’ novel antimicrobial-immunomodulator, Nylexa, which is now set to enter phase 3 clinical trials in the UK for COVID-19 and non-COVID pneumonia (in hospitalised ... The next clinical trials for both of the
-
Clinical trials and the diversity principle
The following month, it happened again. Cambridge, Massachusetts-based Moderna said it had slowed enrolment in its phase 3 COVID-19 vaccine trial to ensure they were getting a representative population. ... With a dozen competitive vaccine trials in
-
October 2020: diversity and inclusion in clinical trials round-up
Underrepresentation in cancer clinical trials. In an effort to explore the age and race distribution of patients within oncology clinical trials, a study looked into phase 3 clinical trials that had ... African American and Asian patients are
-
September 2020: diversity and inclusion in clinical trials round-up
Roughly 1 in 3 don’t participate in clinical trials, get vaccinated or get tested for conditions due to lack of trust. ... Lack of awareness of clinical trials is a barrier faced by Hispanic people with Parkinson’s disease.
More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- My journey advancing the science in pulmonary hypertension
- NHS App to revolutionise digital health and care with major digital updates by 2023
- A new era for UK-Japanese scientific research relations
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- GSK announces The HealthTree Foundation’s multiple myeloma programme as first ‘Think Tank’ challenge winner
- NRG Therapeutics partners with Domainex to develop neurodegenerative disease treatment
- Innovative Trials opens first US office
- Scanning for Health Indicators and Risks Through Your Smartphone
PMHub
Collected Group
Collected Group is a forward thinking healthcare communication company that supports biopharma and diagnostic companies to engage in more lasting...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
